1. Apoptosis as the basic mechanism of cytotoxic action of ursolic and pomolic acids in glioma cells

    Frolova, T. S., Lipeeva, A. V., Baev, D. S., Tsepilov, Y. A. & Sinitsyna, O. I., 1 Sept 2017, In: Molecular Biology. 51, 5, p. 705-711 7 p.

    Research output: Contribution to journalArticlepeer-review

  2. Apoptosis as the basic mechanism of cytotoxic action of ursolic and pomolic acids in glioma cells

    Frolova, T. S., Lipeeva, A. V., Baev, D. S., Tsepilov, Y. A. & Sinitsyna, O. I., 1 Sept 2017, In: Molekuliarnaia biologiia. 51, 5, p. 809-816 8 p.

    Research output: Contribution to journalArticlepeer-review

  3. Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma

    Dyrkheeva, N. S., Zakharenko, A. L., Novoselova, E. S., Chepanova, A. A., Popova, N. A., Nikolin, V. P., Luzina, O. A., Salakhutdinov, N. F., Ryabchikova, E. I. & Lavrik, O. I., Mar 2021, In: Molecular Biology. 55, 2, p. 273-277 5 p.

    Research output: Contribution to journalArticlepeer-review

  4. Antimetastatic Effect of Liposomal Recombinant Lactaptin

    Kaledin, V. I., Koval, O. A., Kuligina, E. V., Lushnikova, E. L., Nikolin, V. P., Popova, N. A., Pyshnaya, I. A. & Richter, V. A., Apr 2018, In: Bulletin of Experimental Biology and Medicine. 164, 6, p. 762-765 4 p.

    Research output: Contribution to journalArticlepeer-review

  5. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma

    Koldysheva, E. V., Men’shchikova, A. P., Lushnikova, E. L., Popova, N. A., Kaledin, V. I., Nikolin, V. P., Zakharenko, A. L., Luzina, O. A., Salakhutdinov, N. F. & Lavrik, O. I., 15 Mar 2019, In: Bulletin of Experimental Biology and Medicine. 166, 5, p. 661-666 6 p.

    Research output: Contribution to journalArticlepeer-review

  6. Anti-inflammatory Effects of Variola Virus TNF Decoy Receptor in an Experimental Model of Contact Dermatitis

    Viazovaia, E. A., Gileva, I. P., Toporkova, L. B., Shchelkunov, S. N. & Orlovskaya, I. A., 1 Jan 2019, In: Current Pharmaceutical Biotechnology. 19, 11, p. 910-916 7 p.

    Research output: Contribution to journalArticlepeer-review

  7. Antibody response to SARS-CoV-2 infection and Sputnik V vaccination

    Тимофеева, А. М., Седых, С. Е. & Невинский, Г. А., 2022, p. 195-195. 1 p.

    Research output: Contribution to conferencePosterpeer-review

  8. Antibodies to highly pathogenic A/H5Nx (Clade 2.3.4.4) influenza viruses in the sera of vietnamese residents

    Ilyicheva, T., Marchenko, V., Pyankova, O., Moiseeva, A., Nhai, T. T., Lan Anh, B. T., Sau, T. K., Kuznetsov, A., Ryzhikov, A. & Maksyutov, R., Apr 2021, In: Pathogens. 10, 4, 394.

    Research output: Contribution to journalArticlepeer-review

  9. Antibodies from human milk hydrolyze microRNAs

    Kompaneets, I., Ermakov, E., Sedykh, S. & Nevinsky, G., Jul 2021, In: FEBS Open Bio. 11, p. 122 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  10. Antibodies Capable of Enhancing SARS-CoV-2 Infection Can Circulate in Patients with Severe COVID-19

    Matveev, A., Pyankov, O., Khlusevich, Y., Tyazhelkova, O., Emelyanova, L., Timofeeva, A., Shipovalov, A., Chechushkov, A., Zaitseva, N., Kudrov, G., Yusubalieva, G., Yussubaliyeva, S., Zhukova, O., Baklaushev, V., Sedykh, S., Lifshits, G., Tikunov, A. & Tikunova, N., 28 Jun 2023, In: International Journal of Molecular Sciences. 24, 13, 10799.

    Research output: Contribution to journalArticlepeer-review

ID: 3083609